Glibenclamide is often used as insulin stimulant in many studies and also as standard antidiabetic drug in STZ-induced moderate diabetes to compare the antidiabetic potential of various hypoglycemic agents (Andrade et al. 2000). Here, INS is linked to diabetes mellitus.